All treatment safety Articles
-
1.0KClinicalThe Latest in Red Light Therapy
June 2, 2025 By Dr. Dzung Tran, Australian College of Optometry (ACO) Repeated low-level red-light (RLRL) therapy is a promising strategy for...
-
751Research ReviewEfficacy and Safety of Low-Dose Atropine in Pre-Myopic Children
May 1, 2025 By Mahmoud Haddara, BSc, OD The use of topical low-dose atropine to slow progression in myopic children is well...
-
1.5KResearch ReviewNavigating Myopia Control: A Simplified Overview of Various Methods for Clinicians
January 2, 2025 By Leila Sara Eppenberger, MD, FEBO, FMH, MSc ETH Over the past few decades, the options for controlling myopia...
-
683Latest Myopia NewsHOYA Presents Eight-Year Clinical Trial Results at IMC
October 7, 2024 HAINAN ISLAND, China — At the 19th International Myopia Conference, HOYA Vision Care shared the eight-year results from its...
-
1.1KResearch ReviewFive-Year Results of Atropine 0.01% Efficacy in Myopia Control in a European Population
October 1, 2024 By Diba Rezazadeh, OD, AdvCertChVis(ACO) Topical low-dose atropine has become a popular myopia control treatment, and its ability to...
-
553ClinicalWhich Myopic Children Will Benefit From Low-Dose Atropine?
August 1, 2024 By Catherine Tay, BOptom, GradCertPublicHealth Environmental factors, genetic factors, and patient characteristics are important determinants that may help guide...
-
1.6KResearch ReviewSeeing Beyond Efficacy
May 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The management of juvenile-onset myopia is a critical public health issue,...
-
2.1KResearch ReviewEfficacy and Safety of Various Atropine Concentrations for Myopia Control
April 1, 2022 By Geetha Sravani, PhD Candidate, Brien Holden Vision Institute Myopia prevalence is high in many Asian countries. To delay...